NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients
In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments
GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways
NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts
Trending Stories
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Karen Knudsen to leave ACS
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72